Last updated 2026-07-20
- Raised $10M Series A led by Sofinnova Partners, Jun 2024
- Raised $5M Seed round led by Sofinnova Partners, Nov 2021
Total raised
$15.0M
Last: Undisclosed Round 2024-07
Stage
Series A
Founded
2019
Headcount
17
HQ
Kfar Saba, Israel
Sector
Health Tech & Life Sciences
About
Endoron Medical is a medtech company specializing in innovative endograft stapling solutions for the endovascular repair of abdominal aortic aneurysms (AAA). The company's flagship product, Aortoseal, is a catheter-based EndoStapling solution designed to secure endografts, prevent long-term migration and endoleaks, and reduce the need for highly invasive open surgeries. Endoron's technology aims to provide a long-lasting sealing and fixation solution for endografts by mimicking hand-sewn suturing with a smart multi-stapling mechanism. The company is currently advancing its Aortoseal product through its Investigational Device Exemption (IDE) approved Early Feasibility Study (EFS).
Funding history · 2 rounds · $15.0M total
2024-06
A Round
$10.0M
★ Sofinnova PartnersEuropean Union’s EIC Fund
2021-11
Seed
$5.0M
★ Sofinnova Partners
Headcount over time
From 2 (2019-11) to 17 (2026-03) · +15 (+750%) · 21 points · source: Finder history + radar grounding
Q&A
- What is Endoron Medical's primary focus?
- Endoron Medical is focused on providing a catheter-based endovascular suturing device for abdominal aortic aneurysms, aiming to offer a long-lasting sealing and fixation solution for endografts.
- When was Endoron Medical founded?
- Endoron Medical was founded in July 2019.
- How many employees does Endoron Medical have?
- Endoron Medical has 11-50 employees.
- What is Endoron Medical's total funding to date?
- Endoron Medical has raised a total of $15,000,000 USD.
- When did Endoron Medical complete its most recent funding round and who were the lead investors?
- Endoron Medical completed a $10,000,000 funding round in July 2024, with Sofinnova Partners and European Union’s.
- What is the current product stage of Endoron Medical's technology?
- Endoron Medical's product is currently in the clinical trial stage.
- What is the name of Endoron Medical's core technology?
- Endoron Medical's core technology is called Aortoseal, designed to mimic hand-sewn suturing for endograft fixation.
- Where is Endoron Medical headquartered?
- Endoron Medical is headquartered in Kefar Sava, Israel.
Team · 3
Ronit Harpaz
Founder · Co-founder & CEO
Prof. Ron Karmeli
Founder · Co-founder & CMO
Eyal Teichman
Founder · Co-founder & CTO
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesMedical Treatment & Therapeutics
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
medical-devicescardiovascularsurgeonssurgeryhospitalsmedical-technologies
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
External links
| Website | endoronmedical.com |
|---|---|
| linkedin.com/company/36139563 |
Identifiers & details
| Legal name | Endoron Medical Ltd. |
|---|---|
| Founded | 2019-7 |
| Employees (exact) | 17 |
Radar intelligence
Patents
| EPO | 4 |
|---|
Web history (Wayback)
| Domain | endoronmedical.com |
|---|
Certificate / subdomain footprint
| Subdomains | 8 |
|---|
Israeli Companies Registrar (רשם החברות / ICA)
| Registrar # (ח.פ.) | 516049129 |
|---|---|
| Status | פעילה |
| Corp type | ישראלית חברה פרטית |
| Incorporated | 2019-07-01 |
| Purpose | לעסוק בכל עיסוק חוקי |
| Liability | מוגבלת |
| In violation (unfiled) | no |
| Last annual report | 2025 |
| Active charges / liens | 0 |
| Registry events | 4 — shares_capital (4) |
| Registered address | עתירי ידע 21 כפר סבא |
Recent registry events
| Date | Event |
|---|---|
| 2025-08-27 | העברת מניות |
| 2025-08-25 | שינוי בהרכב הון - מניות-שינוי סוג מניה |
| 2025-08-12 | שינוי בהרכב הון - מניות-הפחתת הון מוקצה |
| 2025-08-12 | הקצאת מניות |